Transgene Biotek Q4 Results

  • BSE: 526139
  • NSE: -
  • ISIN: INE773D01018
  • Sector: Biotechnology & Drugs
BSE
6.520.03 (0.46%)
Volume16.55 K
Updated: Tue 26 Nov, 2024 | 15:29:24
NSE
This stock is not traded on NSE
Today: 6.51
6.81
52-Wk: 5.79
12.46

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Transgene Biotek Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 0.040.00-%0.00-%
    Selling/ General/ Admin Expenses Total 0.080.08-%0.08-%
    Depreciation/ Amortization 0.021.24-%1.24-%
    Other Operating Expenses Total 0.240.06-%0.09-%
    Total Operating Expense 0.341.38-%1.47-%
    Operating Income -0.29-1.38-%-1.47-%
    Net Income Before Taxes -0.27-1.38-%-1.47-%
    Net Income -0.27-1.38-%-1.47-%
    Diluted Normalized EPS -0.05-0.18-%-0.20-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts